CODX
Co-Diagnostics, Inc. Common Stock
NASDAQ: CODX · HEALTHCARE · MEDICAL DEVICES
$1.53
-6.13% today
Updated 2026-04-29
Market cap
$5.94M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-35.25
Dividend yield
—
52W range
$1 – $47
Volume
1.5M
Co-Diagnostics, Inc. Common Stock (CODX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-925228.00 | $-1.53M | $-1.31M | $-3.21M | $-4.08M | $-5.53M | $28.17M | $41.08M | $6.57M | $-22.08M | $-29.16M | $-29.14M |
| Capital expenditures | $11886.00 | $118465.00 | $12241.00 | $129306.00 | $41336.00 | $113246.00 | $774397.00 | $669463.00 | $1.43M | $1.37M | $748352.00 | $700047.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $45498.00 | $69565.00 | $2.03M | $1.33M | $1.09M | $2.74M | $5.51M | $7.54M | $8.34M | $5.43M | $2.25M |
| Free cash flow | $-937114.00 | $-1.65M | $-1.32M | $-3.34M | $-4.12M | $-5.64M | $27.39M | $40.41M | $5.14M | $-23.45M | $-29.90M | $-29.84M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $2.54M | $-2.58M | $-57099.00 | $42.08M | $45.63M | $-65.63M | — | — | — |